Three subunits of the eukaryotic initiation factor 3 (eIF3) complex are correlated with cancer development—subunit eIF3d possesses cap-binding activity [64]; eIF3G is associated with cancer progression; eIF3h interacts with METTL3 [65,66]. Here, EIF3H is linked to cancer.